A carregar...
Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America
Biological therapies have revolutionized the treatment of several cancers and systemic immune-mediated inflammatory conditions. Expiry of patents protecting a number of biologics has provided the opportunity to commercialize highly similar versions, known as biosimilars. Biosimilars are approved by...
Na minha lista:
| Publicado no: | MAbs |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152448/ https://ncbi.nlm.nih.gov/pubmed/30156950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1484977 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|